Lilly Alzheimer drug fails to hit trial goals
August 24 2012
The company said its experimental Alzheimer's drug Solanezumab's Phase III trial was a bust—the drug failed to meet either of ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.